AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Illumina (ILMN) upgraded to Zacks Rank #1 (Strong Buy) due to rising earnings estimates and a positive earnings outlook. The company's genetic testing tools business is expected to drive growth, with an average annual return of +25% for Zacks Rank #1 stocks since 1988. Institutional investors use earnings estimates to calculate fair value, leading to higher or lower stock prices based on revisions.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet